pfizer
Was Dr. Oz's Apple Juice Arsenic 'Crisis' Just a Ratings Ploy?
11:00AM 9/22/2011
Last week, TV host Dr. Mehmet Oz took on apple juice, declaring that the classic drink may be slowly poisoning America's children with arsenic. But the FDA and the juice companies have credibly refuted his claims. So was Dr. Oz's announcement meant to be a legitimate health warning, or just a cynical attempt to boost ratings?
FDA Urged to Ban 'Dangerous' Alzheimer's Drug
1:30PM 5/24/2011
A consumer advocacy group and professor of geriatric medicine are urging the Food and Drug Administration to yank the strongest dosage of a popular Alzheimer's medication from the market, because they're concerned that it is dangerous and ineffective.
Donepezil, which is marketed by Eisai and...
Is Celgene the Perfect Stock?
2:00PM 4/06/2011
Company News, Technology, Economy, Investing, Health Care, Genzyme Corporation , Pfizer, Merck, Market News, Investment
With an attractive balance sheet, healthy revenue growth and a solid return on equity, biotech company Celgene looks like a promising stock buy.
Pfizer Inc. subsidiary Greenstone LLC recalled one lot of its Citalopram depression medicine and its prostate drug Finasteride because the wrong labels may have been put on the bottles, said the U.S. Food and Drug Administration.
Greenstone said in a recall notice that bottles of Citalopram, a...
Japan Finds No Link Between Vaccines and Child Deaths
12:30PM 3/08/2011
Japan's health ministry says it's continuing its suspension of pediatric vaccines made by Pfizer and Sanofi-Aventis, despite finding no connection between the vaccines and the deaths of four children. Both drugmakers are cooperating with the government and expect to be cleared.
Pfizer and Sanofi-Aventis Vaccines Suspended in Japan
1:50PM 3/07/2011
Two pediatric vaccines have been suspended in Japan after the deaths of four children. Shares of Sanofi-Aventis and Pfizer, which make the drugs, have fallen in midday trading.
In an update Tuesday, Pfizer said it is discontinuing 15 of the projects in its development pipeline. The news comes a month after the world's largest pharmaceutical company announced large research and development cuts were on the way.
The 10 Biggest-Selling Drugs That Are About to Lose Their Patent
8:00AM 2/27/2011
Company News, Investing, Health Care, Johnson & Johnson, Pfizer, Bristol-Myers Squibb, Merck, Eli Lilly, Astrazeneca
The pharmaceutical industry is ready to fall off a cliff -- a "patent cliff." Over the next few years, some of the world's most popular and lucrative medicines will go off patent, and generic competition will siphon an estimated quarter of a trillion dollars from drugmakers' bottom lines.
Supreme Court Limits Lawsuits Against Vaccine Makers
12:11PM 2/23/2011
Vaccine makers such as Pfizer are breathing easier now that the Supreme Court has ruled they can't be sued for defective vaccine designs. The majority opinion by Justice Antonin Scalia was unequivocal: Congress has barred lawsuits over the rare but unavoidable side effects of vital vaccines.
Pfizer 4Q Earnings Nearly Quadruple
12:45AM 2/02/2011
Pfizer beat Wall Street expectations by a slim margin as its profits nearly quadrupled, compared to a 2009 quarter hurt by big restructuring charges. Shares rose more than 5% even though the company warned that revenue is slowing and it plans to cut its workforce.
More Stories
Next Page →Market Movers
| Symbol | Last | Change / % | Volume |
|---|
Most Actives
| 8.07 | -0.11 -1.34% | 254.23M | |
| 2.19 | +0.25 +12.89% | 122.18M | |
| 18.88 | -0.26 -1.33% | 109.55M | |
| 12.44 | -0.25 -1.97% | 52.49M |
% Gainers
| 31.68 | +7.78 +32.55% | 18.42M | |
| 89.96 | +13.57 +17.76% | 13.27M | |
| 2.19 | +0.25 +12.89% | 122.18M | |
| 10.50 | +1.10 +11.70% | 3.07M |
% Losers
DailyFinance Wire
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
- Why Used Car Bargains Are Getting Harder to Find
- 5 Reasons Facebook Stock May Be a Better Buy Than You Think
Newswire
- Staff at The Sun tabloid arrested in bribe...
- Greece's grim choice: deep budget cuts or...
- Greek premier defends bailout deal, painful...
- Faces beyond the numbers of long-term...
- Obama budget: New spending with recycled tax...
- Obama budget seeks to boost trade enforcement
- As Facebook IPO nears, the case for dull stocks
- Turbo-traders take Bank of America for a ride
- Getting paid $35,000 to short sell
- What the $26B settlement means for you
- Investing your emergency cash: Return vs. risk
- First Premier's $400-a-year credit card
- Big banks' bloated mortgage tab
- Fewer young adults hold jobs than ever before
- Government assistance expands
- Bob Rodriguez: The best advice I ever got
- 24/7 Wall St. Top Analyst Calls of the Week (AONE, ALU, AMSC, NLY, AAPL, CSCO, COH, CSTR, COP, DLR, IBM, LF, MMM, M, OPEN, POST, SIRI, SOHU, TRLG, ZOLT)
- The Force: Star Wars Franchise Worth Over $30 Billion and Growing
- 24/7 Wall St. Closing Bell (COP, GILD, AMSC, MA, COH, LNKD, ATVI, CPST, GPRE, KONA, TRLG, LGF, MOVE, NBL, PCYC, ALU, FLIR, RUTH, FSLR, CIE, TBAC, RPXC, AMRS)
- Mid-day Movers (CIE, AMRS, IPSU, MOVE, LNKD)
- Petrobras Shares Volatile on $225 Billion Development Plan (PBR)
- Morning Movers (CIE, ALU, LNKD, AMRS, XIDE)
- AEP Dividend Growth Still Looks Safe Ahead (AEP)
- Arch Coal Tumbles on Earnings, Forecast (ACI, ANR, PCX, BTU, CNX)
Follow Us
